Table 3 Associations between PD-L1, pSTAT3 and other clinicopathologic factors in diffuse large B cell lymphoma (n = 107)
|  | PD-L1i | PD-L1 translocation (A) | PD-L1 gain/amplification (B) | PD-L1 gene alteration (A + B) | PD-L1 non-genetic expressionb | pSTAT3a (continuous) | pSTAT3 (> 40%) |
|---|---|---|---|---|---|---|---|
PD-L1t | R = 0.325 p = 0.001 | R = 0.477 p < 0.001 | R = 0.386 p < 0.001 | R = 0.629 p < 0.001 | R = 0.698 p < 0.001 | R = 0.079 p = 0.429 | R = 0.071 p = 0.466 |
PD-L1i |  | R = 0.239 p = 0.015 | R = 0.159 p = 0.109 | R = 0.291 p = 0.003 | R = 0.166 p = 0.092 | R = 0.081 p = 0.414 | R = 0.015 p = 0.879 |
PD-L1 translocation (A) |  |  | R = − 0.051 p = 0.614 | R = 0.758 p < 0.001 | R = − 0.090 p = 0.364 | R = − 0.049 p = 0.628 | R = − 0.037 p = 0.714 |
PD-L1 gain/amplification (B) |  |  |  | R = 0.613 p < 0.001 | R = − 0.073 p = 0.464 | R = − 0.117 p = 0.242 | R = − 0.072 p = 0.470 |
PD-L1 gene alteration (A + B) |  |  |  |  | R = − 0.120 p = 0.228 | R = − 0.117 p = 0.245 | R = − 0.021 p = 0.835 |
PD-L1 non-genetic expressionb |  |  |  |  |  | R = 0.205 p = 0.033 | R = 0.120 p = 0.224 |